Gliclazide Group Medications

This tender, identified by process code SIE-CMFIEDM-2025-028-748941, concerns the procurement of medications belonging to the Gliclazide group. The contracting entity is the CENTRO MEDICO FAMILIAR INTEGRAL Y ESPECIALIDADES, DIALISIS LA MARISCAL. The procurement modality is Electronic Reverse Auction.

The specific item required is Gliclazide, presented in oral solid form with prolonged release. Each unit is specified as 60 mg, packaged in boxes of blister packs/strips. The total quantity required is 240,000 units, with an estimated value of USD 158,250.00. This procurement is crucial for ensuring the availability of essential medication for patients requiring treatment with Gliclazide, likely for managing diabetes. The electronic reverse auction format suggests a competitive bidding process where suppliers will have the opportunity to lower their prices to secure the contract. Interested parties should review the detailed specifications and bidding instructions provided by the contracting entity to participate effectively in this tender. The focus on a specific dosage and release form indicates a need for precise pharmaceutical products to meet patient care standards.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of USD 158,250.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.